MB Therapeutics celebrates its firts anniversary!
One year ago, MB Therapeutics began its journey with a clear mission: to bring innovative solutions to the healthcare sector. Today, we celebrate a year filled with achievements, marked by strong partnerships, an ambitious strategic roadmap, and a structured team for the future.
A first year of innovation and growth
Since its inception, MB Therapeutics has made significant progress:
-
Strategic partnerships : We have developed lasting relationships with our partners, particularly with pharmacists, who are key players in the healthcare ecosystem. These partnerships enhance our ability to offer innovative therapeutic solutions and accelerate their adoption in the market.
-
Vision 2026 roadmap : From the very first year, we launched our long-term strategic plan, the 2026 vision. This roadmap sets clear goals to strengthen our role in therapeutic innovation. MB Therapeutics is committed to long-term innovation to provide more effective, personalized, and accessible treatments for every patient.
-
Team structuring : We have built a dedicated and passionate team, ligned with MB’s goals and values. With this team, we have the necessary resources to execute our projects with efficiency and rigor.
The promising future of MB Therapeutics
While we celebrate our first anniversary today, MB Therapeutics remains firmly focused on the future. The coming years will be marked by major advancements in implementing our Vision 2026 and introducing new innovative new therapeutic solutions to the market.
Our commitment is to continue innovating in healthcare by establishing new strategic partnerships while staying true to our slogan: MADE FOR YOU MEDS, every medication for everyone.
THANK YOU to those who contribute for our success
We would like to express our heartfelt thanks to our clients, partners, and team members. Thanks to you, MB Therapeutics can continue its commitment to a more innovative and effective future in medicine.
Today, we are proud to develop a turnkey solution for the production of next-generation personalized medications in pharmacies. A huge thank you to the pharmacists who believe in the future of 3D-printed medications and who, every day, support us in providing their patients with tailored treatments that are more innovative than ever. Ian Soulairol & Stéphane Roulon, Co-founders of MB Therapeutics
